GSK reports small rise as Pfizer deal approved

13 May 2019 - Deborah Wilkes

Premium

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 1% at constant exchange rates in the first quarter of 2019. The company's shareholders have just approved the proposed consumer healthcare joint venture with Pfizer.

Click tags below for more information on topics:

GlaxoSmithKline Pfizer

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: